{"id":"https://openalex.org/W2889757285","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.2527","title":"A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without systemic bevacizumab, for patients with advanced cancer and liver involvement.","display_name":"A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without systemic bevacizumab, for patients with advanced cancer and liver involvement.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2889757285","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.2527","mag":"2889757285"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.2527","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.2527","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.2527","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089796322","display_name":"Elena Fountzilas","orcid":"https://orcid.org/0000-0002-4884-2544","observed_orcids":["https://orcid.org/0000-0002-4884-2544"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Fountzilas","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009189690","display_name":"Elangovan Krishnan","orcid":"https://orcid.org/0009-0003-5345-7848","observed_orcids":["https://orcid.org/0009-0003-5345-7848"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elangovan Krishnan","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071800834","display_name":"Filip Jank\u00fa","orcid":"https://orcid.org/0000-0002-8123-4065","observed_orcids":["https://orcid.org/0000-0002-8123-4065"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Filip Janku","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045197829","display_name":"Siqing Fu","orcid":"https://orcid.org/0000-0002-1933-0419","observed_orcids":["https://orcid.org/0000-0002-1933-0419"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siqing Fu","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008786567","display_name":"Daniel D. Karp","orcid":"https://orcid.org/0000-0002-5017-328X","observed_orcids":["https://orcid.org/0000-0002-5017-328X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel D. Karp","raw_affiliation_strings":["Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005436649","display_name":"Aung Naing","orcid":"https://orcid.org/0000-0002-4803-8513","observed_orcids":["https://orcid.org/0000-0002-4803-8513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aung Naing","raw_affiliation_strings":["University of Texas, MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043675371","display_name":"Vivek Subbiah","orcid":"https://orcid.org/0000-0002-6064-6837","observed_orcids":["https://orcid.org/0000-0002-6064-6837"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek Subbiah","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David S. Hong","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026538331","display_name":"Sarina Anne Piha-Paul","orcid":"https://orcid.org/0000-0001-9455-1660","observed_orcids":["https://orcid.org/0000-0001-9455-1660"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarina Anne Piha-Paul","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052731379","display_name":"David J. Vining","orcid":"https://orcid.org/0000-0003-3233-5406","observed_orcids":["https://orcid.org/0000-0003-3233-5406"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J Vining","raw_affiliation_strings":["Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044840107","display_name":"Apostolia Maria Tsimberidou","orcid":"https://orcid.org/0000-0003-2713-233X","observed_orcids":["https://orcid.org/0000-0003-2713-233X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Apostolia Maria Tsimberidou","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"2527","last_page":"2527"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatic-arterial-infusion-chemotherapy","display_name":"hepatic arterial infusion chemotherapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.6690000295639038},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7720000147819519},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9710000157356262},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8349999785423279},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.3889999985694885},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5070000290870667},{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.7269999980926514},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8539999723434448},{"id":"https://openalex.org/keywords/metastatic-biliary-tract-cancer","display_name":"metastatic biliary tract cancer","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9518104195594788},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.909429132938385},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.855925440788269},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.8249756097793579},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6351592540740967},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5903112888336182},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5761030316352844},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5643880367279053},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.46939200162887573},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4080369472503662},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3986179232597351},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.38479793071746826},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34687870740890503}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.2527","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.2527","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.2527","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8600000143051147}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1520918055","https://openalex.org/W2377024980","https://openalex.org/W2361525411","https://openalex.org/W4234281245","https://openalex.org/W2799922918","https://openalex.org/W2373559083","https://openalex.org/W2378173381","https://openalex.org/W2356910782","https://openalex.org/W2011752462","https://openalex.org/W2361275302"],"abstract_inverted_index":{"2527":[0],"Background:":[1],"Hepatic":[2],"arterial":[3],"infusion":[4],"(HAI)":[5],"of":[6,46,153,263,269],"chemotherapy":[7],"is":[8],"a":[9],"treatment":[10,216,227,356],"option":[11],"for":[12,217,228],"patients":[13],"(pts)":[14],"with":[15,26,33,53,235,244],"cancer":[16,32],"metastatic":[17],"to":[18,78,106,355],"the":[19,170,183],"liver.":[20],"We":[21],"investigated":[22],"HAI":[23,39,186,232],"oxaliplatin":[24,40,187,233],"combined":[25,234],"capecitabine":[27,47,190,236],"+/-":[28,237],"bevacizumab,":[29],"in":[30,99,118,175,209,247],"advanced":[31],"liver":[34,140],"involvement.":[35],"Methods:":[36],"Pts":[37,96],"received":[38],"(140":[41],"mg/m2)":[42],"and":[43,50,146,173,193,204,241],"escalating":[44],"doses":[45],"(500,":[48],"750,":[49],"1000":[51,179],"mg/m2),":[52],"(Arm":[54,58,88],"A)":[55],"or":[56,111],"without":[57],"B)":[59],"bevacizumab":[60,107,194,238],"(10":[61],"mg/kg":[62],"IV).":[63],"A":[64,89,120],"3+3":[65],"dose":[66],"design":[67],"was":[68,114,127,156,169,185,239,242],"used,":[69],"followed":[70],"by":[71],"an":[72],"expansion":[73],"phase.":[74],"Results:":[75],"From":[76],"9/2009":[77],"2/2014,":[79],"61":[80,267],"pts":[81,162,177,213,223,264,271],"(34":[82],"men,":[83],"27":[84],"women)":[85],"were":[86,97,136,199],"enrolled":[87],"=":[90,94,109,122],"44;":[91],"Arm":[92,100,119],"B":[93,101],"17).":[95],"treated":[98],"if":[102,112],"they":[103],"had":[104,163],"contraindications":[105],"(n":[108,121],"13)":[110],"there":[113],"no":[115],"spot":[116],"available":[117],"4).":[123],"The":[124,132,150],"median":[125,151],"age":[126],"60":[128],"yrs":[129],"(range,":[130,158],"20-88).":[131],"most":[133],"common":[134],"cancers":[135],"colorectal":[137],"(22":[138],"pts),":[139],"(13),":[141],"pancreas":[142],"(7),":[143],"breast":[144],"(4),":[145],"biliary":[147],"tract":[148],"(4).":[149],"number":[152],"prior":[154],"therapies":[155],"3":[157,167,304,329,335],"1-12);":[159],"32":[160],"(53%)":[161],"previously":[164],"oxaliplatin.":[165],"Grade":[166],"diarrhea":[168],"only":[171],"DLT":[172],"occurred":[174],"2":[176,332],"receiving":[178],"mg/m2":[180],"capecitabine.":[181],"Thus,":[182],"MTD":[184],"140":[188],"mg/m2,":[189,192],"750":[191],"10":[195],"mg/kg.":[196],"Common":[197],"toxicities":[198],"anemia,":[200],"thrombocytopenia,":[201],"neutropenia,":[202],"hypomagnesemia,":[203],"nausea/vomiting.":[205],"Outcomes":[206],"are":[207],"shown":[208],"Table.":[210],"Eleven":[211],"(18%)":[212],"remained":[214,225],"on":[215,226,323],"\u22656":[218],"months,":[219],"including":[220],"4":[221],"(6.6%)":[222],"who":[224],"\u22651":[229],"year.":[230],"Conclusions:":[231],"well-tolerated":[240],"associated":[243],"favorable":[245],"outcomes":[246],"selected":[248],"pts.":[249],"Clinical":[250],"trial":[251],"information:":[252],"NCT01213238.":[253],"Oxaliplatin":[254,258],"HAI,":[255,259],"Capecitabine,":[256],"Bevacizumab":[257],"Capecitabine":[260],"Total":[261],"No.":[262,268],"44":[265],"17":[266],"evaluable":[270],"36":[272],"11":[273],"47":[274],"CR+PR":[275],"(%)":[276,284,293],"8":[277],"(22)":[278],"1":[279],"(9)":[280],"9":[281,287],"(19)":[282],"SD":[283],"26":[285],"(72)":[286],"(81)":[288],"35":[289],"(75)":[290],"SD\u22654":[291],"months":[292,301,312,325],"14":[294,297],"(39)":[295],"0":[296],"(30)":[298],"Median":[299,310,321],"TTF,":[300],"(95%":[302,313,326],"CI)":[303,314,327],"(2.27-3.73)":[305],"1.5":[306],"(1.0-2.0)":[307],"2.7":[308],"(2.4-3.0)":[309],"OS,":[311],"7.1":[315],"(5.46-8.8)":[316],"6.2":[317],"(3.16-9.17)":[318],"7":[319],"(5.57-8.56)":[320],"time":[322,354],"Rx,":[324],"(Range)":[328],"(2.35-3.65)":[330],"(1-21)":[331,337],"(1.56-2.47)":[333],"(1-15)":[334],"(2.48-3.53)":[336],"*":[338],"CR":[339],"complete":[340],"response,":[341,347],"OS:":[342],"overall":[343],"survival,":[344],"PR:":[345],"partial":[346],"Rx:":[348],"treatment,":[349],"SD:":[350],"stable":[351],"disease,":[352],"TTF:":[353],"failure":[357]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}